Henosis Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-12-2024
- Paid Up Capital ₹ 0.10 M
as on 06-12-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
as on 06-12-2024
- Revenue 474.63%
(FY 2022)
- Profit 25.74%
(FY 2022)
- Ebitda 113.62%
(FY 2022)
- Net Worth -1083.47%
(FY 2022)
- Total Assets 43.73%
(FY 2022)
About Henosis Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Thekke Rajeesh and Vadakkottil Sreejesh serve as directors at the Company.
- CIN/LLPIN
U24304KL2020PTC064823
- Company No.
064823
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Oct 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kozhikode, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Henosis Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thekke Rajeesh  | Director | 05-Oct-2020 | Current |
| Vadakkottil Sreejesh | Director | 05-Oct-2020 | Current |
Financial Performance of Henosis Pharmaceutical.
Henosis Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 474.63% increase. The company also saw a substantial improvement in profitability, with a 25.74% increase in profit. The company's net worth observed a substantial decline by a decrease of 1083.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Henosis Pharmaceutical?
In 2021, Henosis Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jun 2023 | State Bank Of India | ₹1.00 M | Open |
How Many Employees Work at Henosis Pharmaceutical?
Henosis Pharmaceutical has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Henosis Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Henosis Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.